Concert Pharmaceuticals Inc

NASDAQ:CNCE   3:41:51 PM EDT
3.43
-0.20 (-5.51%)
Earnings Announcements

Concert Pharma Reports Third Quarter 2021 Financial Results

Published: 11/09/2021 12:19 GMT
Concert Pharmaceuticals Inc (CNCE) - Concert Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Company Update.
Q3 Loss per Share $0.78.
Q3 Revenue $500,000 Versus $1.5 Million.
Expects Its Cash and Cash Equivalents to Fund Company Into Q4 of 2022.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.73

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.58

More details on our Analysts Page.